Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Pramipexole

Copy Product Info
😃Good
Catalog No. T1476Cas No. 104632-26-0
Alias SND 919

Pramipexole (SND 919) is a selective dopamine receptor agonist used in the therapy of Parkinson disease. Pramipexole therapy is associated with a low rate of transient serum enzyme elevations during treatment but has not been implicated in cases of clinically apparent acute liver injury.

Pramipexole

Pramipexole

Copy Product Info
😃Good
Purity: 99.96%
Catalog No. T1476Alias SND 919Cas No. 104632-26-0
Pramipexole (SND 919) is a selective dopamine receptor agonist used in the therapy of Parkinson disease. Pramipexole therapy is associated with a low rate of transient serum enzyme elevations during treatment but has not been implicated in cases of clinically apparent acute liver injury.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
500 mg$30In StockIn Stock
1 g$47InquiryInquiry
1 mL x 10 mM (in DMSO)$32In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.96%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Pramipexole AI Summary
Pramipexole exhibits high binding affinity for human dopamine receptor subtypes D3 (Ki = 0.45 nM) and D2 long (Ki = 27.0 nM), with moderate affinity for D2 short (Ki = 60.0 nM) and D4.4 (Ki = 8.5 nM). It shows agonist activity at these subtypes, with respective EC50 values of 1.0 nM for D3, 9.2 nM for rat D2 long, and 15.0 nM for human D4.2 receptors. Pramipexole also demonstrates high intrinsic activity (up to 100.0%) across these receptors, indicating its strong potential to modulate dopaminergic activity. Additionally, Pramipexole exhibits antiviral activities, notably inhibiting SARS-CoV-2 in VERO-6 cells, and interacts broadly with other receptor types including serotonin and histamine receptors, as well as demonstrating moderate liver toxicity and significant affinity for tyrosyl-DNA phosphodiesterase 1. It has high solubility and oral bioavailability (90.0%), making it a promising candidate for further pharmacological investigations..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Pramipexole (SND 919) is a selective dopamine receptor agonist used in the therapy of Parkinson disease. Pramipexole therapy is associated with a low rate of transient serum enzyme elevations during treatment but has not been implicated in cases of clinically apparent acute liver injury.
Targets&IC50
D2S receptor:3.9 nM(Ki), D4 receptor:5.1 nM(Ki), D2L receptor:2.2 nM(Ki), D3 receptor:0.5 nM(Ki)
SynonymsSND 919
Chemical Properties
Molecular Weight211.33
FormulaC10H17N3S
Cas No.104632-26-0
SmilesCCCN[C@H]1CCc2c(C1)sc(N)n2
Relative Density.1.17 g/cm3 (Predicted)
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 75 mg/mL (354.9 mM), Sonication is recommended.
H2O: < 1 mg/mL (insoluble or slightly soluble)
Ethanol: 39 mg/mL (184.55 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (9.46 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
Ethanol/DMSO
1mg5mg10mg50mg
1 mM4.7319 mL23.6597 mL47.3194 mL236.5968 mL
5 mM0.9464 mL4.7319 mL9.4639 mL47.3194 mL
10 mM0.4732 mL2.3660 mL4.7319 mL23.6597 mL
20 mM0.2366 mL1.1830 mL2.3660 mL11.8298 mL
50 mM0.0946 mL0.4732 mL0.9464 mL4.7319 mL
100 mM0.0473 mL0.2366 mL0.4732 mL2.3660 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Pramipexole | purchase Pramipexole | Pramipexole cost | order Pramipexole | Pramipexole chemical structure | Pramipexole formula | Pramipexole molecular weight